For certain members of the scientific community. For example, Hiroyuki Matsuoka of Jichi Medical University in Japan said that he was working on a modified mosquito.
That could generate and inject a malaria vaccine protein into a host’s epidermis with the support of a 2008 Gates Foundation funding. In 2022, Sean Murphy and his colleagues.
At the University of Washington established what they referred to as a “proof of concept” for the technique by testing human immunisations against malaria spread by mosquitoes.
Similar to this, Dutch researchers at the LUMC looked at genetically engineered parasites and mosquito carriers.
As a possible substitute for the short-lived and very weakly effective malaria vaccines presently licensed by the World Health Organisation.
The efficiency of GA1, a malaria parasite that has been genetically altered to cease growing in humans after around 24 hours of infection,
